COMPANY PROFILE

Metrodora Institute

A medical and research center dedicated to advancing care and accelerating cures for people living with neuroimmune axis disorders

Salt Lake City, United StatesFounded 2020Biotech & Life Sciences

Valuation $100–250M Last recorded · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Metrodora Institute

Metrodora Institute is a pioneering medical center focused on the neuroimmune axis, which involves the interaction between the nervous and immune systems. The institute serves patients with complex neurological and immune disorders, offering a unique blend of clinical care and cutting-edge research. Operating in the healthcare sector, Metrodora collaborates with leaders in biotech, biopharma, and academia to drive medical discoveries and develop new treatments. The business model revolves around providing specialized medical services, conducting groundbreaking research, and forming strategic partnerships to advance healthcare. Revenue is generated through patient care services, research grants, and collaborative projects with industry leaders.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Salt Lake City, United States
Employees: 39
Open positions: None listed
Dealroom signal: 56.3/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Medical Research, Tech for Medical Professionals, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b, b2c
Links: Website

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Apr 2023	$35M	$140M	Undisclosed	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Metrodora Institute website traffic

Latest recorded traffic for Metrodora Institute is 280 monthly website visits, up 460% over the last three months. Metrodora Institute's team grew 0% over the past year.

Latest monthly visits280 3-month web change+460% 1-year team growth0%

Monthly website visitsApr 2023–May 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
R(Research Grid (R.grid)AI-powered automation engine for admin-free clinical trials	Norwich, United Kingdom	Operational	40	$14M	$33M
MTMISSION TherapeuticsTherapeutics targeting deubiquitylating enzymes for mitochondrial dysfunction diseases	Cambridge, United Kingdom	Operational
LALabConnectLabConnect enhances lives by collaborating with pharma/biotech firms and CROs to speed up global medicine development	Johnson City, United States	Operational
KEKernelNeuroscience as a Service enables on-demand access to the world's most advanced brain recording technology	Culver City, United States	Operational
NONotableAI platform automating healthcare administrative workflows	San Mateo, United States	Operational
QEQ.B.I. EnterprisesClinical-Stage Pharmaceutical Company	Fremont, United States	Operational
TGTongshu GeneA high-tech enterprise that focuses on scientific and technological innovation and focuses on precise molecular diagnosis of tumors	China	Operational
CLCliniNoteEnables data-driven medicine	Warsaw, Poland	Operational